Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Primary liver cancer is a challenging global health concern with an estimated more than a
million persons to be affected annually by the year 2025. The commonest type is …

Hepatocellular carcinoma (HCC) is estimated to be the third leading cause of cancer-related
mortality and is characterized by low survival rates. Nonalcoholic fatty liver disease (NAFLD) …

Background Abbreviated MRI is a proposed paradigm shift for hepatocellular carcinoma
(HCC) surveillance, but data on its performance are lacking for histopathologically confirmed …

Hepatocellular carcinoma (HCC) is highly prevalent and the third most common cause of
cancer-related death in Asia. In contrast to the West, the main etiology of HCC in many Asian …

Highlights•The incidence of HCC will continue to rise.•HCC is curable at an early
stage.•New locoregional treatments such as radioembolisation are showing impressive …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of developing
hepatocellular carcinoma (HCC), especially among those who have cirrhosis or advanced …